William A. Garvin | Buchanan Ingersoll & Rooney PC

JUN 14 2024

DeSantis Vetoes Bill That Would Have Banned Some Delta-8 THC Products

MALLORY HARRELL NATALIE C. OEHLERS W. PIERCE SCHUESSLER WILLIAM A. GARVIN

CANNABIS

JUN 10 2024

5 Ways AI is Impacting Life Science Companies Right Now

BARBARA A. BINZAK BLUMENFELD, PH.D. CAROLINE BASSETT WARREN DANIEL R. LAZARO JAMES T. WILCOX JASON R. PARISH JONATHAN D. JANOW LLOYD FREEMAN MARK A. KASTEN MICHAEL G. MCLAUGHLIN TINA HU-RODGERS

ADVANCED TECHNOLOGY CYBERSECURITY & DATA PRIVACY FDA & BIOTECHNOLOGY INTELLECTUAL PROPERTY LABOR & EMPLOYMENT LIFE SCIENCES LIFE SCIENCES LITIGATION PRODUCT LIABILITY

APR 18 2024

Change is Afoot for the Cannabis Landscape in Florida

MALLORY HARRELL NATALIE C. OEHLERS WILLIAM A. GARVIN

CANNABIS LIFE SCIENCES

NOV 2 2023

White House Issues Groundbreaking Executive Order on Artificial Intelligence

JEFFREY M. LAGANA MICHAEL G. MCLAUGHLIN SUE C. FRIEDBERG TINA HU-RODGERS WILLIAM A. GARVIN

ADVANCED TECHNOLOGY CYBERSECURITY & DATA PRIVACY GOVERNMENT RELATIONS & PUBLIC POLICY

OCT 16 2023

Artificial Intelligence and Machine Learning: The Next Frontier of Drug Development?

TINA HU-RODGERS WILLIAM A. GARVIN

ADVANCED TECHNOLOGY FDA & BIOTECHNOLOGY LIFE SCIENCES

SEP 11 2023

Adjusting Position: HHS Recommends the Rescheduling of Marijuana Under the CSA

NATALIE C. OEHLERS WILLIAM A. GARVIN

CANNABIS FDA & BIOTECHNOLOGY LIFE SCIENCES

AUG 16 2023

Key Steps To Prepare for FDA's New Medical Device Cybersecurity Rules

TINA HU-RODGERS WILLIAM A. GARVIN

ADVANCED TECHNOLOGY CYBERSECURITY & DATA PRIVACY FDA & BIOTECHNOLOGY GOVERNMENT RELATIONS & PUBLIC POLICY LIFE SCIENCES

JUL 11 2023

FDA and FTC Issue Warning to Six Companies Selling Delta-8 THC Products

NATALIE C. OEHLERS WILLIAM A. GARVIN

CANNABIS FDA & BIOTECHNOLOGY LIFE SCIENCES

FEB 15 2023

2023 Is Set To Bring a Wave of COVID-19 Fraud Enforcement in Life Sciences

GEORGE M. KARAVETSOS MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

LIFE SCIENCES LIFE SCIENCES LITIGATION WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS

JUN 6 2022

Court Rules Delta-8 THC Products Now Legal

NATALIE C. OEHLERS WILLIAM A. GARVIN

CANNABIS FDA & BIOTECHNOLOGY LIFE SCIENCES TRADEMARK

MAY 26 2022

FDA Issues Flurry of Warning Letters to Companies Making Unapproved Claims about CBD and Delta-8 Products

NATALIE C. OEHLERS WILLIAM A. GARVIN

CANNABIS FDA & BIOTECHNOLOGY LIFE SCIENCES

MAY 28 2021

HHS and FDA Withdraw Previous Notice, Reinstitute Unapproved Drug Initiative

TINA HU-RODGERS WILLIAM A. GARVIN

FDA & BIOTECHNOLOGY LIFE SCIENCES

MAR 30 2021

FDA Reissues OTC Monograph User Fees

TINA HU-RODGERS WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

JAN 8 2021

HHS Washes Its Hands of FDA's OTC Sanitizer User Fees

TINA HU-RODGERS WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

JAN 4 2021

More FDA Enforcement Against CBD Companies

TINA HU-RODGERS WILLIAM A. GARVIN

CANNABIS

DEC 18 2020

Operation CBDeceit: FTC Cracks Down on False and Misleading CBD Advertising

CARRIE G. AMEZCUA TINA HU-RODGERS WILLIAM A. GARVIN

CANNABIS

NOV 24 2020

HHS Ends FDA's Unapproved Drug Initiative

WILLIAM A. GARVIN

FDA & BIOTECHNOLOGY LIFE SCIENCES

JUN 5 2020

Cannabis Amid COVID-19: 4 Ways Coronavirus Impacts the Cannabis Market

JAMES D. NEWELL JENNIFER R. MINTER WILLIAM A. GARVIN

CANNABIS CORONAVIRUS (COVID-19)

MAY 8 2020

How Life Sciences Companies Can Help Fight COVID-19 with the FDA's Emergency Use Authorization

BARBARA A. BINZAK BLUMENFELD, PH.D. WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

APR 9 2020

In the Chaos of COVID-19 Pandemic, What is "Current" in cGMP?

EDWARD JOHN ALLERA WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

APR 8 2020

Asking What You Can Do for Your Hospital: Producing and Providing Personal Protective Equipment and Products to Combat COVID-19

WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

MAR 25 2020

FDA Shifts Approach to CBD Products: Exploring Safe, Regulated Products & Relaxed Enforcement

TINA HU-RODGERS WILLIAM A. GARVIN

CANNABIS FDA & BIOTECHNOLOGY LIFE SCIENCES

MAR 23 2020

Clinical Trial Data in the Time of COVID-19

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

NOV 27 2019

FDA Takes Aggressive Action Against CBD Products

TINA HU-RODGERS WILLIAM A. GARVIN

CANNABIS

NOV 1 2019

USDA Issues Interim Domestic Hemp Production Rule: What Does This Highly Anticipated Rule Mean for the Cannabis Industry?

MALLORY HARRELL WILLIAM A. GARVIN

CANNABIS GOVERNMENT RELATIONS & PUBLIC POLICY

JUN 6 2019

A Recap from the FDA’s Public Hearing on Cannabis or Cannabis-Derived Compounds

MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

CANNABIS LIFE SCIENCES

JUN 3 2019

The ABCs of CBD: 5 Big Questions Businesses Should Ask Before Entering the CBD Market

WILLIAM A. GARVIN

CANNABIS LIFE SCIENCES

DEC 21 2018

Farm Bill Creates Legal Framework for Hemp

WILLIAM A. GARVIN

2017 TAX ACT ADVANCED TECHNOLOGY AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT ANTI-HARASSMENT & WORKPLACE CONDUCT TRAINING ANTITRUST & TRADE REGULATION APPELLATE ATTORNEY UPDATE AUTONOMOUS & CONNECTED VEHICLES BANKRUPTCY & CREDITORS' RIGHTS BLOCKCHAIN & DIGITAL ASSETS

JUN 26 2018

FDA Approves First Cannabis Product as Drug

TINA HU-RODGERS WILLIAM A. GARVIN

FDA & BIOTECHNOLOGY LIFE SCIENCES

JAN 5 2018

Sessions' Announcement Rattles Cannabis Industry

MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

SEP 24 2015

Executive Leaders Radio - September 30, 2015

EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

JUL 1 2015

FDA Practice Partners With FGR Practice to Deliver Successful Client Outcomes

EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

GOVERNMENT RELATIONS & PUBLIC POLICY

JUN 3 2015

Executive Leaders Radio - June 3, 2015

EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

MAR 20 2015

Executive Leaders Radio - April 8, 2015

MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

MAR 12 2013

Beware the Ides of March

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA TINA HU-RODGERS WILLIAM A. GARVIN

2017 TAX ACT ADVANCED TECHNOLOGY AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT ANTI-HARASSMENT & WORKPLACE CONDUCT TRAINING ANTITRUST & TRADE REGULATION APPELLATE ATTORNEY UPDATE AUTONOMOUS & CONNECTED VEHICLES BANKRUPTCY & CREDITORS' RIGHTS BLOCKCHAIN & DIGITAL ASSETS

FEB 8 2012

Sharp increase in threatened lawsuits against food and beverage clients

EDWARD JOHN ALLERA WILLIAM A. GARVIN

2017 TAX ACT ADVANCED TECHNOLOGY AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT ANTI-HARASSMENT & WORKPLACE CONDUCT TRAINING ANTITRUST & TRADE REGULATION APPELLATE ATTORNEY UPDATE AUTONOMOUS & CONNECTED VEHICLES BANKRUPTCY & CREDITORS' RIGHTS BLOCKCHAIN & DIGITAL ASSETS

APR 5 2011

The Nanotechnology Revolution: Are FDA and the Public Ready for It?

EDWARD JOHN ALLERA WILLIAM A. GARVIN

APR 5 2011

Follow-on Biologics – Update for Clients

WILLIAM A. GARVIN

INTELLECTUAL PROPERTY